News & Updates

Show Multimedia Only

Postop use of wearables OK for patients

22 Jan 2026 by

According to a survey, integrating wearables into postoperative care is well-received among hospitalized postop patients, paving the way for their future implementation.

Postop use of wearables OK for patients

22 Jan 2026

HPV genotyping enhances risk stratification of cervical samples

22 Jan 2026 by

A comprehensive human papillomavirus (HPV) genotyping in combination with cytology improves risk stratification of cervical samples and patient management, suggests a Singapore study.

HPV genotyping enhances risk stratification of cervical samples

22 Jan 2026

TyG index tied to emotional well-being in women with hypertension

22 Jan 2026

The association between triglyceride-glucose (TyG) index and emotional states is stronger in women than in men, suggests a study.

TyG index tied to emotional well-being in women with hypertension

22 Jan 2026

FLAURA2 regimen achieves median OS of nearly 4 years in EGFR-mutated advanced NSCLC

22 Jan 2026 by

First-line osimertinib plus chemotherapy demonstrated a median overall survival (mOS) of nearly 4 years in patients with EGFR-mutated (exon 19 deletion or L858R mutation) advanced non-small-cell lung cancer (NSCLC) in the final OS analysis of the FLAURA 2 trial.

FLAURA2 regimen achieves median OS of nearly 4 years in EGFR-mutated advanced NSCLC

22 Jan 2026

First phase III results show PFS benefit with pirtobrutinib vs BR in treatment-naïve CLL/SLL

22 Jan 2026 by

Single-agent pirtobrutinib significantly improved progression-free survival (PFS) vs bendamustine plus rituximab (BR) for patients with treatment-naïve chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), according to the first results from the phase III BRUIN CLL-313 trial.

First phase III results show PFS benefit with pirtobrutinib vs BR in treatment-naïve CLL/SLL

22 Jan 2026

SGLT2i may delay hormone therapy failure in prostate cancer

22 Jan 2026 by

Intention-to-treat (ITT) SGLT2 inhibitor (SGLTi) use was associated with reduced risk of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitor (APRI) failure, according to findings of a population-based study in Hong Kong.

SGLT2i may delay hormone therapy failure in prostate cancer

22 Jan 2026

Nonadherence to PAH medications compromises outcomes

22 Jan 2026

Patients with pulmonary arterial hypertension (PAH) who do not adhere to medications appear to have poor clinical outcomes, according to a study.

Nonadherence to PAH medications compromises outcomes

22 Jan 2026

Inpatient rehab improves post-stroke upper limb function

22 Jan 2026 by

Stroke survivors who underwent inpatient rehabilitation experienced significant improvements in upper extremity (UE) impairment and in related UE-dependent activities of daily living (ADL), according to a recent study in Singapore.

Inpatient rehab improves post-stroke upper limb function

22 Jan 2026

Prenatal benzodiazepine use poses risk of adverse pregnancy outcomes

21 Jan 2026

The use of benzodiazepine during pregnancy has been associated with elevated risks of preterm birth and small for gestational age in a recent study.

Prenatal benzodiazepine use poses risk of adverse pregnancy outcomes

21 Jan 2026

$Liposomal irinotecan plus nimotuzumab takes on immunotherapy-refractory NPC$

Liposomal irinotecan plus nimotuzumab takes on immunotherapy-refractory NPC

21 Jan 2026 by

In patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) refractory to immune checkpoint inhibitor (ICI) therapy, the combination of liposomal irinotecan plus nimotuzumab yields meaningful clinical activity while having favourable tolerability, as shown in a phase II study.

Liposomal irinotecan plus nimotuzumab takes on immunotherapy-refractory NPC

21 Jan 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Postop use of wearables OK for patients

Postop use of wearables OK for patients

HPV genotyping enhances risk stratification of cervical samples

HPV genotyping enhances risk stratification of cervical samples

TyG index tied to emotional well-being in women with hypertension

TyG index tied to emotional well-being in women with hypertension

FLAURA2 regimen achieves median OS of nearly 4 years in EGFR-mutated advanced NSCLC

FLAURA2 regimen achieves median OS of nearly 4 years in EGFR-mutated advanced NSCLC

First phase III results show PFS benefit with pirtobrutinib vs BR in treatment-naïve CLL/SLL

First phase III results show PFS benefit with pirtobrutinib vs BR in treatment-naïve CLL/SLL

SGLT2i may delay hormone therapy failure in prostate cancer

SGLT2i may delay hormone therapy failure in prostate cancer

Nonadherence to PAH medications compromises outcomes

Nonadherence to PAH medications compromises outcomes

Inpatient rehab improves post-stroke upper limb function

Inpatient rehab improves post-stroke upper limb function

Prenatal benzodiazepine use poses risk of adverse pregnancy outcomes

Prenatal benzodiazepine use poses risk of adverse pregnancy outcomes

Liposomal irinotecan plus nimotuzumab takes on immunotherapy-refractory NPC

Liposomal irinotecan plus nimotuzumab takes on immunotherapy-refractory NPC